AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
48 hedge funds and large institutions have $18.8M invested in AVEO Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $29.6M → $18.8M (-$10.8M)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
48
Holding in Top 10
2
Calls
$108K
Puts
$54K
Top Buyers
| 1 | +$120K | |
| 2 | +$64K | |
| 3 | +$13K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$12.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$393K | |
| 3 | -$211K | |
| 4 |
Two Sigma Investments
New York
|
-$163K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$154K |